|
|
Volumn 5, Issue , 2012, Pages
|
|
The significance of 18F-FDG PET/CT in secondary hemophagocytic lymphohistiocytosis
a,b
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
FLUORODEOXYGLUCOSE F 18;
DIAGNOSTIC AGENT;
RADIOPHARMACEUTICAL AGENT;
ADOLESCENT;
ADULT;
AGED;
ARTICLE;
CLINICAL ARTICLE;
COMPUTER ASSISTED EMISSION TOMOGRAPHY;
FEMALE;
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS;
HUMAN;
INFECTION ASSOCIATED HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS;
MALE;
MALIGNANCY ASSOCIATED HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS;
METABOLISM;
RHEUMATOSIS ASSOCIATED HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS;
STANDARDIZATION;
STATISTICAL SIGNIFICANCE;
DIFFERENTIAL DIAGNOSIS;
EPSTEIN BARR VIRUS;
EPSTEIN BARR VIRUS INFECTION;
HEMOPHAGOCYTIC SYNDROME;
MIDDLE AGED;
NEOPLASM;
PATHOGENICITY;
PROGNOSIS;
ADOLESCENT;
ADULT;
AGED;
DIAGNOSIS, DIFFERENTIAL;
EPSTEIN-BARR VIRUS INFECTIONS;
FEMALE;
FLUORODEOXYGLUCOSE F18;
HERPESVIRUS 4, HUMAN;
HUMANS;
LYMPHOHISTIOCYTOSIS, HEMOPHAGOCYTIC;
MALE;
MIDDLE AGED;
NEOPLASMS;
POSITRON-EMISSION TOMOGRAPHY AND COMPUTED TOMOGRAPHY;
PROGNOSIS;
RADIOPHARMACEUTICALS;
YOUNG ADULT;
|
|
EID: 84865203900
PISSN: None
EISSN: 17568722
Source Type: Journal
DOI: 10.1186/1756-8722-5-40 Document Type: Article |
|
Times cited : (20)
|
|
References (6)
|
